TKNO

Healthcare Drug Manufacturers - Specialty & Generic

Alpha Teknova, Inc.

$8.55
-0.20 -2.29% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 7, 2026, live at 10:26 AM ET8.55

Key Stats

Market Cap
459.03M
Avg Volume
231,241
EPS
-$0.31
52W High
$9.48
52W Low
$1.91
Div. Yield
0.0%

Analyst Ratings

Buy
0
Str Buy
7
Buy
1
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
-45.00
P/B Ratio
7.33
P/S Ratio
10.50
EV/EBITDA
-53.47
EV/Revenue
10.98

Margins

Gross Margin 34.6%
Operating Margin (23.7%)
Net Margin (38.4%)
EBITDA Margin (20.5%)

Growth & Returns

Revenue Growth (YoY)
18.5%
Return on Equity
(24.2%)
Return on Assets
(9.3%)

Liquidity & Leverage

Current Ratio
4.49
Quick Ratio
3.32
Debt / Equity
0.44
Total Cash
17.44M
Total Debt
27.41M

About

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

www.teknova.com